首页> 外国专利> GINSENOSIDE COMPOSITION HAVING ALCOHOLIC FATTY LIVER-PREVENTING AND -TREATING FUNCTION

GINSENOSIDE COMPOSITION HAVING ALCOHOLIC FATTY LIVER-PREVENTING AND -TREATING FUNCTION

机译:人参皂苷组合物具有含酒精脂肪肝防止和 - 治疗功能

摘要

Disclosed in the present invention is a ginsenoside composition having an alcoholic fatty liver-preventing and -treating function. The pharmaceutical composition able to be used to prevent and/or treat alcoholic fatty liver of the present invention contains a prophylactically and/or therapeutically effective dose of ginsenoside Rk3 and ginsenoside Rh4 as active ingredients, and a pharmaceutically acceptable carrier. In the pharmaceutical composition, the mass ratio between the ginsenoside Rk3 and the ginsenoside Rh4 is 1:0.5-2, and is preferably 1:0.9-1.1. The ginsenoside composition of the present invention is able to markedly improve liver function index abnormalities caused by a large amount of alcohol consumption, reducing the generation of inflammatory infiltrates and fat vacuoles in liver tissue. The present invention provides a synergistically interacting pharmaceutical composition containing ginsenosides Rk3 and Rh4 and having alcoholic fatty liver-preventing and/or -treating effects.
机译:本发明公开了一种具有醇脂肪肝防止和 - 治疗功能的人参皂苷组合物。能够用于预防和/或治疗本发明的酒精脂肪肝的药物组合物含有预防和/或治疗有效剂量的人参皂苷RK3和人参皂苷RH4作为活性成分,以及药学上可接受的载体。在药物组合物中,人参皂苷RK3和人参皂苷RH4之间的质量比为1:0.5-2,优选为1:0.9-1.1。本发明的人参皂苷组合物能够显着提高由大量醇消耗引起的肝功能指数异常,从而减少肝组织中炎性浸润和脂肪液泡的产生。本发明提供了一种含有人参皂苷RK3和RH4的协同交互的药物组合物,并具有含酒精的脂肪肝防止和/或-治疗效果。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号